⌘K

Login Start Free

Home/Filings/4/0001140361-21-008342

4//SEC Filing

Wrighton-Smith Peter 4

Accession 0001140361-21-008342

CIK 0001586049other

View on SEC.gov Company Profile

Filed

Mar 11, 7:00 PM ET

Accepted

Mar 12, 4:35 PM ET

Size

19.6 KB

Accession

0001140361-21-008342

Insider Transaction Report

Form 4

Period: 2021-03-08

Oxford Immunotec Global PLCOXFD

Wrighton-Smith Peter

DirectorChief Executive Officer

Transactions

Disposition to Issuer
Ordinary Shares
2021-03-08$22.00/sh−400,225$8,804,950→ 0 total
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.88/sh−41,931$330,416→ 0 total
Exercise: $14.12Exp: 2025-06-19→ Ordinary Shares (41,931 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$8.50/sh−105,255$894,668→ 0 total
Exercise: $13.50Exp: 2027-02-24→ Ordinary Shares (105,255 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$8.76/sh−103,330$905,171→ 0 total
Exercise: $13.24Exp: 2028-03-15→ Ordinary Shares (103,330 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$5.58/sh−67,959$379,211→ 0 total
Exercise: $16.42Exp: 2029-04-01→ Ordinary Shares (67,959 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$9.81/sh−62,087$609,073→ 0 total
Exercise: $12.19Exp: 2030-03-11→ Ordinary Shares (62,087 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$11.79/sh−128,959$1,520,427→ 0 total
Exercise: $10.21Exp: 2026-03-04→ Ordinary Shares (128,959 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.43/sh−51,403$381,924→ 0 total
Exercise: $14.57Exp: 2025-01-16→ Ordinary Shares (51,403 underlying)

Footnotes (3)

[F1]Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited (the "Bidco") of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
[F2]In connection with the Scheme, all stock options were transferred to Bidco in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price.
[F3]Represents the payment per ordinary share received in exchange for the transfer of each option of $22.00, less the applicable exercise price.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

Oxford Immunotec Global PLC

CIK 0001586049

Entity typeother

Related Parties

1

filerCIK 0001592286

Filing Metadata

Form type: 4
Filed: Mar 11, 7:00 PM ET
Accepted: Mar 12, 4:35 PM ET
Size: 19.6 KB

View on SEC.gov